MX2020006443A - Combinacion de un retinoide y un extracto de silybum marianum (l.) gaertn. - Google Patents
Combinacion de un retinoide y un extracto de silybum marianum (l.) gaertn.Info
- Publication number
- MX2020006443A MX2020006443A MX2020006443A MX2020006443A MX2020006443A MX 2020006443 A MX2020006443 A MX 2020006443A MX 2020006443 A MX2020006443 A MX 2020006443A MX 2020006443 A MX2020006443 A MX 2020006443A MX 2020006443 A MX2020006443 A MX 2020006443A
- Authority
- MX
- Mexico
- Prior art keywords
- combination
- gaertn
- retinoid
- extract
- silybum marianum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/11—Aldehydes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
Abstract
La presente invención se refiere a la combinación de un retinoide y un extracto de SIlybum marianum(L). Gaertn, las composiciones dermatológicas y dermocosméticas que contienen dicha combinación, así como sus usos como un producto medicinal, en particular en el tratamiento del acné, la seborrea, la dermatitis seborreica y/o la rosácea.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1762606A FR3075037B1 (fr) | 2017-12-20 | 2017-12-20 | Association d'un retinoide et d'un extrait de silybum marianum (l.) gaertn |
| PCT/EP2018/086326 WO2019122203A1 (fr) | 2017-12-20 | 2018-12-20 | Association d'un rétinoïde et d'un extrait de silybum marianum (l.) gaertn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020006443A true MX2020006443A (es) | 2020-09-17 |
Family
ID=61187541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020006443A MX2020006443A (es) | 2017-12-20 | 2018-12-20 | Combinacion de un retinoide y un extracto de silybum marianum (l.) gaertn. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11690886B2 (es) |
| EP (1) | EP3727413B1 (es) |
| JP (1) | JP7404240B2 (es) |
| KR (1) | KR102800277B1 (es) |
| CN (1) | CN111511380B (es) |
| AU (1) | AU2018387304B2 (es) |
| CA (1) | CA3085663C (es) |
| ES (1) | ES2975069T3 (es) |
| FR (1) | FR3075037B1 (es) |
| MX (1) | MX2020006443A (es) |
| PL (1) | PL3727413T3 (es) |
| SG (1) | SG11202005600RA (es) |
| TW (1) | TWI821226B (es) |
| WO (1) | WO2019122203A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3099699B1 (fr) | 2019-08-06 | 2025-09-26 | Fabre Pierre Dermo Cosmetique | Extrait d’akènes de Silybum marianum (L.) Gaertn. pour promouvoir la croissance capillaire |
| FR3113585B1 (fr) * | 2020-08-31 | 2025-11-21 | Pierre Fabre Dermo Cosmetique | Huile de Silybum marianum (L.) Gaertn. dans le renforcement de la fonction barrière de la peau |
| WO2023161200A1 (en) * | 2022-02-22 | 2023-08-31 | Dsm Ip Assets B.V. | Retinol formulation (v) |
| FR3148366A1 (fr) * | 2023-05-04 | 2024-11-08 | Pierre Fabre Dermo-Cosmetique | Extraits enrichis en oxylipines, issus de Silybum marianum (L.) Gaertn. |
| FR3151199A1 (fr) * | 2023-07-21 | 2025-01-24 | Pierre Fabre Dermo-Cosmetique | Extrait d’akènes de Silybum marianum (L.) Gaertn. pour le traitement ou la prévention de rougeurs cutanées |
| CN118178391B (zh) * | 2024-05-14 | 2024-07-16 | 深圳北京大学香港科技大学医学中心 | 异水飞蓟宾a在缓解玫瑰痤疮中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2084569B (en) | 1980-09-29 | 1984-02-15 | Madaus & Co Dr | Extraction of silymarin |
| FR2594691B1 (fr) * | 1986-02-24 | 1990-08-03 | Bonne Claude | Nouvelles preparations cosmetiques contenant un extrait des fruits de silybum marianum |
| CN1076589A (zh) * | 1993-01-01 | 1993-09-29 | 吴宗民 | 营养保健油 |
| JP2000169332A (ja) * | 1998-12-09 | 2000-06-20 | Kanebo Ltd | 皮脂分泌抑制剤および皮膚化粧料 |
| US6492326B1 (en) * | 1999-04-19 | 2002-12-10 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
| AU2000231423A1 (en) * | 2000-03-03 | 2001-09-12 | Shu-Wen Lee | Specific therapeutic composition for treating aids |
| JP2004501952A (ja) | 2000-06-30 | 2004-01-22 | ユニリーバー・ナームローゼ・ベンノートシヤープ | レチノイン酸の皮膚への効果を模倣するための化合物を含むスキンコンディショニング組成物 |
| WO2010080543A1 (en) * | 2008-12-18 | 2010-07-15 | Guthery B Eugene | Acne vulgaris treatment regimen |
| KR20100079586A (ko) | 2008-12-31 | 2010-07-08 | 구례군 | 엉겅퀴 추출물을 함유하는 항아토피 피부염 조성물 |
| CN104673486B (zh) | 2015-02-13 | 2018-07-06 | 安徽嘉旗粮油工程技术有限公司 | 一种从水飞蓟饼中同时提取水飞蓟油和水飞蓟素的方法 |
| WO2017037534A1 (en) * | 2015-09-06 | 2017-03-09 | Prestigio Ltd. | Topical compositions for treatment of psoriasis |
| CN106332982A (zh) * | 2016-08-28 | 2017-01-18 | 乌苏市盛维生物工程有限公司 | 一种食用调和油及其制备方法 |
-
2017
- 2017-12-20 FR FR1762606A patent/FR3075037B1/fr active Active
-
2018
- 2018-12-19 TW TW107145963A patent/TWI821226B/zh active
- 2018-12-20 EP EP18836821.1A patent/EP3727413B1/fr active Active
- 2018-12-20 WO PCT/EP2018/086326 patent/WO2019122203A1/fr not_active Ceased
- 2018-12-20 US US16/955,729 patent/US11690886B2/en active Active
- 2018-12-20 PL PL18836821.1T patent/PL3727413T3/pl unknown
- 2018-12-20 JP JP2020534176A patent/JP7404240B2/ja active Active
- 2018-12-20 AU AU2018387304A patent/AU2018387304B2/en active Active
- 2018-12-20 CA CA3085663A patent/CA3085663C/fr active Active
- 2018-12-20 MX MX2020006443A patent/MX2020006443A/es unknown
- 2018-12-20 CN CN201880081943.8A patent/CN111511380B/zh active Active
- 2018-12-20 KR KR1020207018544A patent/KR102800277B1/ko active Active
- 2018-12-20 ES ES18836821T patent/ES2975069T3/es active Active
- 2018-12-20 SG SG11202005600RA patent/SG11202005600RA/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020011661A2 (pt) | 2020-11-17 |
| EP3727413B1 (fr) | 2024-01-03 |
| CN111511380B (zh) | 2022-05-24 |
| RU2020123260A (ru) | 2022-01-20 |
| CA3085663A1 (fr) | 2019-06-27 |
| TWI821226B (zh) | 2023-11-11 |
| WO2019122203A1 (fr) | 2019-06-27 |
| AU2018387304B2 (en) | 2024-04-04 |
| JP7404240B2 (ja) | 2023-12-25 |
| EP3727413A1 (fr) | 2020-10-28 |
| SG11202005600RA (en) | 2020-07-29 |
| FR3075037B1 (fr) | 2020-07-17 |
| ES2975069T3 (es) | 2024-07-03 |
| CN111511380A (zh) | 2020-08-07 |
| JP2021506884A (ja) | 2021-02-22 |
| PL3727413T3 (pl) | 2024-05-06 |
| FR3075037A1 (fr) | 2019-06-21 |
| KR20200101929A (ko) | 2020-08-28 |
| US20210069273A1 (en) | 2021-03-11 |
| CA3085663C (fr) | 2024-10-01 |
| KR102800277B1 (ko) | 2025-04-24 |
| TW201927294A (zh) | 2019-07-16 |
| EP3727413C0 (fr) | 2024-01-03 |
| AU2018387304A1 (en) | 2020-07-02 |
| US11690886B2 (en) | 2023-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020006443A (es) | Combinacion de un retinoide y un extracto de silybum marianum (l.) gaertn. | |
| MX2021001091A (es) | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington. | |
| WO2018226622A8 (en) | Compounds for treating huntington's disease | |
| AU2016255707A8 (en) | Uses of cannabidiol for treatment of infantile spasms | |
| MY197635A (en) | Benzooxazole derivatives as immunomodulators | |
| MX386086B (es) | Composicion de cannabis | |
| MX2022005290A (es) | Compuestos heterociclicos como inmunomoduladores. | |
| WO2014188276A3 (en) | Antioxidant compositions and methods of using the same | |
| MX2017011884A (es) | Composiciones cosmeticas topicas contra radicales libres. | |
| EA201791299A1 (ru) | Микроинкапсулированные композиции каннабиноидов | |
| BR122021018243A8 (pt) | Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável | |
| PH12018501084B1 (en) | Heterocyclic compounds as immunomodulators | |
| MY160249A (en) | Fatty acid fumarate derivatives and their uses | |
| EP4414376A3 (en) | Novel depsipeptide and uses thereof | |
| MX2022008479A (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. | |
| MX381044B (es) | Composición que contiene extracto o fracción de plantas del género justicia. | |
| MX2018016032A (es) | Nuevo extracto de aquenio silybum marianum y usos del mismo en la dermatologia y dermocosmeticos. | |
| MX367321B (es) | Composición para el cuidado de la piel y métodos para la misma. | |
| WO2019098811A3 (ko) | Chp(시클로-히스프로)를 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물 | |
| MX391147B (es) | Composiciones para diferenciación y proliferación celular que comprenden la combinación de un extracto de acmella oleracea (espilantol) con extracto de camellia sinensis. | |
| WO2015079469A8 (en) | Daphne laureola extracts in the treatment of dermopathies | |
| MX2016014970A (es) | Composicion cosmetica antitranspirante y desodorante que tiene accion dermocalmante. | |
| SA518400776B1 (ar) | تركيبة للعناية بالبشرة وطريقتها | |
| UA130333C2 (uk) | Композиції, які містять кромогліцієву кислоту, для лікування дерматиту | |
| MY189383A (en) | Soyasaponin-containing composition for skin whitening |